HK1020317A1 - Use of 2-phenyl 1-1,2-benzisoselenazol3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease - Google Patents

Use of 2-phenyl 1-1,2-benzisoselenazol3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease

Info

Publication number
HK1020317A1
HK1020317A1 HK99105534A HK99105534A HK1020317A1 HK 1020317 A1 HK1020317 A1 HK 1020317A1 HK 99105534 A HK99105534 A HK 99105534A HK 99105534 A HK99105534 A HK 99105534A HK 1020317 A1 HK1020317 A1 HK 1020317A1
Authority
HK
Hong Kong
Prior art keywords
alzheimer
phenyl
treatment
disease
producing
Prior art date
Application number
HK99105534A
Other languages
English (en)
Inventor
Ikuo Maruyama
Kazuhiro Abeyama
Hiroyuki Masayasu
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of HK1020317A1 publication Critical patent/HK1020317A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK99105534A 1996-08-27 1999-11-29 Use of 2-phenyl 1-1,2-benzisoselenazol3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease HK1020317A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27
PCT/DE1997/000701 WO1998008511A1 (de) 1996-08-27 1997-04-07 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit

Publications (1)

Publication Number Publication Date
HK1020317A1 true HK1020317A1 (en) 2000-04-14

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99105534A HK1020317A1 (en) 1996-08-27 1999-11-29 Use of 2-phenyl 1-1,2-benzisoselenazol3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease

Country Status (29)

Country Link
US (1) US5948800A (pl)
EP (1) EP0826370B1 (pl)
KR (1) KR20000035859A (pl)
CN (1) CN1112922C (pl)
AT (1) ATE219361T1 (pl)
AU (2) AU3866997A (pl)
BR (1) BR9711259A (pl)
CA (1) CA2213794C (pl)
CZ (1) CZ295364B6 (pl)
DE (2) DE59707550D1 (pl)
DK (1) DK0826370T3 (pl)
EE (1) EE03953B1 (pl)
ES (1) ES2177849T3 (pl)
FI (1) FI119622B (pl)
HK (1) HK1020317A1 (pl)
HU (1) HU225264B1 (pl)
IL (1) IL127113A (pl)
LT (1) LT4602B (pl)
LV (1) LV12251B (pl)
NO (1) NO312812B1 (pl)
NZ (1) NZ332292A (pl)
PL (1) PL188481B1 (pl)
PT (1) PT826370E (pl)
SI (1) SI9720060B (pl)
TR (1) TR199700858A2 (pl)
TW (1) TW501925B (pl)
UA (1) UA59367C2 (pl)
WO (2) WO1998008511A1 (pl)
ZA (1) ZA977644B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE190487T1 (de) * 1993-10-27 2000-04-15 Daiichi Seiyaku Co Granuläre zubereitung
JP2000016935A (ja) 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
WO2000058281A1 (fr) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
IL127113A0 (en) 1999-09-22
CZ295364B6 (cs) 2005-07-13
CN1112922C (zh) 2003-07-02
HUP9903213A3 (en) 2000-12-28
AU725534B2 (en) 2000-10-12
EP0826370A1 (de) 1998-03-04
NO312812B1 (no) 2002-07-08
NZ332292A (en) 2001-07-27
US5948800A (en) 1999-09-07
LV12251A (lv) 1999-04-20
KR20000035859A (ko) 2000-06-26
AU3529897A (en) 1998-03-05
SI9720060A (sl) 1999-06-30
CA2213794C (en) 2006-10-03
TW501925B (en) 2002-09-11
HUP9903213A1 (en) 2000-07-28
CN1223580A (zh) 1999-07-21
LT99016A (en) 1999-10-25
LV12251B (lv) 1999-08-20
PT826370E (pt) 2002-10-31
AU3866997A (en) 1998-03-19
CZ31799A3 (cs) 1999-11-17
FI982689A0 (fi) 1998-12-11
DE59707550D1 (de) 2002-07-25
ATE219361T1 (de) 2002-07-15
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
WO1998008511A1 (de) 1998-03-05
TR199700858A2 (xx) 1998-03-21
EP0826370B1 (de) 2002-06-19
HU225264B1 (en) 2006-08-28
FI982689A (fi) 1998-12-11
FI119622B (fi) 2009-01-30
WO1998008831A1 (fr) 1998-03-05
LT4602B (lt) 2000-01-25
PL321796A1 (en) 1998-03-02
ZA977644B (en) 1999-02-26
NO973912D0 (no) 1997-08-26
EE03953B1 (et) 2003-02-17
UA59367C2 (uk) 2003-09-15
CA2213794A1 (en) 1998-02-27
IL127113A (en) 2003-07-06
EE9900007A (et) 1999-06-15
NO973912L (no) 1998-03-02
BR9711259A (pt) 1999-08-17
SI9720060B (en) 2001-12-31
ES2177849T3 (es) 2002-12-16
PL188481B1 (pl) 2005-02-28

Similar Documents

Publication Publication Date Title
HK1020317A1 (en) Use of 2-phenyl 1-1,2-benzisoselenazol3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease
HUP0103654A2 (hu) Szmilagenin és/vagy anzurogenin-D alkalmazása Alzheimer-kór kezelésére szolgáló gyógyszerkészítmény előállítására
CA2264097A1 (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
NZ504419A (en) The use of carvedilol for treating amyloid diseases such as Alzheimer's
HUT58204A (en) Magnesium-pyridoxale-5'-phosphate-glutaminate for preventing diseases originated from blood-vessel-alternations
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer's disease.
CA2078700A1 (en) Imidazolylmethyl-pyridines
IL99659A0 (en) Cooking pan with capsular base
ZA915462B (en) Composition for the treatment of alzheimer's disease and process for preparing the same
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU2002318888A1 (en) Metal Chelators for use in the treatment of Alzheimer's Disease
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA9469B (en) Use of idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of alzheimer-type senile dementia and of pre-alzheimer's syndrome and their progression
AU2002315098A1 (en) Macrocycles useful in the treatment of alzheimer's disease
AU2002348687A1 (en) Macrocycles useful in the treatment of alzheimer's disease
AU2002346015A1 (en) Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti
AU2002301084A1 (en) Identification of agents for use in the treatment of alzheimer's disease
AU2002324446A1 (en) Substituted aminoalcohols useful in treatment of alzheimer's disease
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130407